These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780 [TBL] [Abstract][Full Text] [Related]
3. Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts. Kim YH; Wee YM; Choi MY; Lim DG; Kim SC; Han DJ Mol Med; 2011; 17(7-8):697-708. PubMed ID: 21365122 [TBL] [Abstract][Full Text] [Related]
4. Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation. Lohan P; Murphy N; Treacy O; Lynch K; Morcos M; Chen B; Ryan AE; Griffin MD; Ritter T Front Immunol; 2018; 9():2666. PubMed ID: 30515159 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model. Jia Z; Jiao C; Zhao S; Li X; Ren X; Zhang L; Han ZC; Zhang X Exp Eye Res; 2012 Sep; 102():44-9. PubMed ID: 22800963 [TBL] [Abstract][Full Text] [Related]
6. Prevention of acute liver allograft rejection by IL-10-engineered mesenchymal stem cells. Niu J; Yue W; Song Y; Zhang Y; Qi X; Wang Z; Liu B; Shen H; Hu X Clin Exp Immunol; 2014 Jun; 176(3):473-84. PubMed ID: 24527865 [TBL] [Abstract][Full Text] [Related]
7. The Timing of Immunomodulation Induced by Mesenchymal Stromal Cells Determines the Outcome of the Graft in Experimental Renal Allotransplantation. Merino A; Ripoll E; de Ramon L; Bolaños N; Goma M; Bestard O; Lloberas N; Grinyo JM; Ambròs JT Cell Transplant; 2017 Jun; 26(6):1017-1030. PubMed ID: 28160460 [TBL] [Abstract][Full Text] [Related]
8. Immune Tolerance of Human Dental Pulp-Derived Mesenchymal Stem Cells Mediated by CD4⁺CD25⁺FoxP3⁺ Regulatory T-Cells and Induced by TGF-β1 and IL-10. Hong JW; Lim JH; Chung CJ; Kang TJ; Kim TY; Kim YS; Roh TS; Lew DH Yonsei Med J; 2017 Sep; 58(5):1031-1039. PubMed ID: 28792150 [TBL] [Abstract][Full Text] [Related]
10. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model. Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894 [TBL] [Abstract][Full Text] [Related]
11. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets. Li H; Wang W; Wang G; Hou Y; Xu F; Liu R; Wang F; Xue J; Hu T; Luan X Cytotherapy; 2015 Nov; 17(11):1560-71. PubMed ID: 26432559 [TBL] [Abstract][Full Text] [Related]
12. Human Adipose Tissue-Derived Mesenchymal Stromal Cells Inhibit CD4+ T Cell Proliferation and Induce Regulatory T Cells as Well as CD127 Expression on CD4+CD25+ T Cells. Fiori A; Uhlig S; Klüter H; Bieback K Cells; 2021 Jan; 10(1):. PubMed ID: 33401501 [TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes. Xu K; Ma D; Zhang G; Gao J; Su Y; Liu S; Liu Y; Han J; Tian M; Wei C; Zhang L Mol Immunol; 2021 Jul; 135():36-44. PubMed ID: 33857817 [TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Selmani Z; Naji A; Zidi I; Favier B; Gaiffe E; Obert L; Borg C; Saas P; Tiberghien P; Rouas-Freiss N; Carosella ED; Deschaseaux F Stem Cells; 2008 Jan; 26(1):212-22. PubMed ID: 17932417 [TBL] [Abstract][Full Text] [Related]
15. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo. Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237 [TBL] [Abstract][Full Text] [Related]
16. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment. Cassano JM; Schnabel LV; Goodale MB; Fortier LA Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127 [TBL] [Abstract][Full Text] [Related]
17. Combined intrathymic and intravenous injection of mesenchymal stem cells can prolong the survival of rat cardiac allograft associated with decrease in miR-155 expression. Huang H; He J; Teng X; Yu Y; Ye W; Hu Y; Shen Z J Surg Res; 2013 Dec; 185(2):896-903. PubMed ID: 23870834 [TBL] [Abstract][Full Text] [Related]
20. Investigation of the effect of IFN-γ/TNF-α-treated mesenchymal stem cells on Th9- and Treg cell-related parameters in a mouse model of ovalbumin-induced allergic asthma. Nozari P; Mokhtari P; Nemati M; Zainodini N; Taghipour Z; Asadi F; Ayoobi F; Jafarzadeh A Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):773-785. PubMed ID: 35620857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]